MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 235 filers reported holding MYRIAD GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $285,000 | -25.8% | 15,662 | +2.6% | 0.00% | 0.0% |
| Q1 2022 | $384,000 | -2.8% | 15,268 | +6.7% | 0.00% | 0.0% |
| Q4 2021 | $395,000 | -14.7% | 14,311 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $463,000 | -16.4% | 14,341 | -46.8% | 0.00% | -80.0% |
| Q3 2016 | $554,000 | -67.5% | 26,936 | -51.6% | 0.01% | -68.8% |
| Q2 2016 | $1,704,000 | -48.8% | 55,693 | -37.4% | 0.02% | -50.0% |
| Q1 2016 | $3,331,000 | -11.9% | 88,998 | +1.6% | 0.03% | -15.8% |
| Q4 2015 | $3,781,000 | +15.1% | 87,593 | -0.0% | 0.04% | +8.6% |
| Q3 2015 | $3,284,000 | +7.1% | 87,612 | -2.9% | 0.04% | +16.7% |
| Q2 2015 | $3,067,000 | – | 90,247 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |